The potential modulation of cGAS sensitivity to dsDNA by HMGB1 presents a novel perspective for pharmacological intervention in ischemic stroke through HMGB1 antagonists or monoclonal antibodies. The gene discussed is HMGB1; the disease is ischemic stroke.